Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin S Weber

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 21, 2021
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20-Yet Progress ContinuesEsther S Frisch, Roxanne Pretzsch, Martin S Weber
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2021
Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 PandemicMartin S Weber, Jacqueline A Nicholas, Michael R Yeaman
Therapeutic Advances in Neurological Disorders|April 7, 2018
Defining distinct features of anti-MOG antibody associated central nervous system demyelinationMartin S Weber, Tobias Derfuss, Imke Metz, et al.
Therapeutic Advances in Neurological Disorders|May 2, 2013
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challengesKlaus Lehmann-Horn, Helena C Kronsbein, Martin S Weber
Expert Opinion on Therapeutic Targets|June 5, 2023
Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosisDarius Saberi, Anastasia Geladaris, Sarah Dybowski, et al.
Current Opinion in Immunology|June 5, 2025
Animal models of autoimmune encephalitisEstibaliz Maudes, Jesús Planagumà, Martin S Weber, et al.
Trends in Immunology|March 15, 2006
A neuropeptide in immune-mediated inflammation, Y?Thomas Prod'homme, Martin S Weber, Lawrence Steinman, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: using statins to treat neuroinflammatory diseaseMartin S Weber, Thomas Prod'homme, Lawrence Steinman, et al.
The Lancet. Neurology|August 20, 2005
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of actionCinthia Farina, Martin S Weber, Edgar Meinl, et al.
Frontiers in Immunology|March 3, 2020
Editorial: Multiple Sclerosis - From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on PatientsPaulus S Rommer, Martin S Weber, Zsolt Illes, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 21, 2021
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20-Yet Progress ContinuesEsther S Frisch, Roxanne Pretzsch, Martin S Weber
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2021
Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 PandemicMartin S Weber, Jacqueline A Nicholas, Michael R Yeaman
Therapeutic Advances in Neurological Disorders|April 7, 2018
Defining distinct features of anti-MOG antibody associated central nervous system demyelinationMartin S Weber, Tobias Derfuss, Imke Metz, et al.
Therapeutic Advances in Neurological Disorders|May 2, 2013
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challengesKlaus Lehmann-Horn, Helena C Kronsbein, Martin S Weber
Expert Opinion on Therapeutic Targets|June 5, 2023
Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosisDarius Saberi, Anastasia Geladaris, Sarah Dybowski, et al.
Current Opinion in Immunology|June 5, 2025
Animal models of autoimmune encephalitisEstibaliz Maudes, Jesús Planagumà, Martin S Weber, et al.
Trends in Immunology|March 15, 2006
A neuropeptide in immune-mediated inflammation, Y?Thomas Prod'homme, Martin S Weber, Lawrence Steinman, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: using statins to treat neuroinflammatory diseaseMartin S Weber, Thomas Prod'homme, Lawrence Steinman, et al.
The Lancet. Neurology|August 20, 2005
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of actionCinthia Farina, Martin S Weber, Edgar Meinl, et al.
Frontiers in Immunology|March 3, 2020
Editorial: Multiple Sclerosis - From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on PatientsPaulus S Rommer, Martin S Weber, Zsolt Illes, et al.
Pageof 14